Membrane Progestin Receptors: Beyond the Controversy, Can We Move Forward?

Total Page:16

File Type:pdf, Size:1020Kb

Membrane Progestin Receptors: Beyond the Controversy, Can We Move Forward? Article in press - uncorrected proof BioMol Concepts, Vol. 1 (2010), pp. 41–47 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BMC.2010.001 Review Membrane progestin receptors: beyond the controversy, can we move forward? Amel Salhi, Julie Lemale, Nicolas Paris, May also been reported to have biological effects within minutes, Bloch-Faure and Gilles Crambert* as well as effects in cells or tissues devoid of their specific nuclear receptors. These rapid and non-classical effects were UPMC Univ Paris 6/INSERM/CNRS, Centre de Recherche originally described for progesterone (1) and then reported des Cordeliers, UMRS 872 Equipe 3 Laboratoire de for all major classes of steroids (2, 3), and particularly for Ge´nomique, Physiologie et Physiopathologie Re´nales progesterone in various physiological contexts such as ERL 7226, F-75006, Paris, France oocyte maturation (4), induction of acrosomal reaction in * Corresponding author sperm wfor review see Ref. (5)x, and activation of calcium e-mail: [email protected] uptake by renal proximal tubules (6, 7). Many explanations have been put forward to support these observations wfor review see Ref. (8) and Figure 1x: (i) the disturbance of the Abstract membrane fluidity by insertion of a lipophilic molecule in the lipid bilayer which can then influence activity of trans- Steroids are well-known mediators of many different physi- porters, channels etc.; (ii) the action of nuclear receptors at ological functions. Their best characterized mechanism of the plasma membrane; (iii) the action of nuclear receptor co- action involves interaction with well-defined nuclear recep- regulators released upon receptor activation by the hormone; tors and regulation of gene transcription. However, rapid and (iv) involvement of a membrane-bound receptor, unre- effects of steroids have been reported which are incompatible lated to the classical nuclear receptor. In view of the plethoric with their classical long-term/slow effects. Although the con- physiological and pathophysiological effects of steroids, the cept of membrane-bound receptors for steroids which can discovery of such receptors and the characterization of their transduce their rapid effects has been proposed many years signaling pathways could have considerable importance, for ago, it is only recently that such proteins have been identified instance to envisage new therapeutic strategies. and characterized. In this review, we will discuss recent data In this review, we will discuss one example, namely the regarding the rapid action of progesterone mediated by newly hormone progesterone, and the recent and controversial iden- characterized membrane-bound receptors belonging to the tification of the so-called membrane progestin receptors progestin and adiponectin receptor family. (mPRs). The purpose of this paper is to contribute to the Keywords: membrane-bound receptors; non-genomic debate initiated by Fernandes et al. (9), who proposed to action; progesterone; steroid. share different points of view present in this field. Introduction Original observations and subsequent work by the Peter Thomas group The way in which steroids act is mainly described as a slow process involving gene transcription. This mechanism, During the late 1980s and early 1990s, the Peter Thomas known as the ‘‘genomic’’ pathway, was postulated more than group at the Marine Science Institute of the University of 60 years ago. During the past decades, this mechanism has Texas (Austin, TX, USA) identified a novel progestin (17,20- been investigated and particularly well described. It involves b,21-trihydroxy-4-pregnen-3-one or 20b-S) as the oocyte (i) the transport of steroid into the cell (either passively or maturation-inducing steroid in the teleost species (10, 11). using putative carriers); (ii) the binding of the hormone to The binding of this novel progestin was shown to occur at receptors trapped in the cytoplasm; (iii) the dimerization and the plasma membrane of oocytes with rapid dissociation and translocation of the ligand–receptor complex to the nucleus; association rates (12). To identify the putative receptors and (iv) the binding to specific nucleotide motifs and acti- involved in the binding of this steroid, this group developed vation of transcription (Figure 1). The receptors mediating an original and elegant multisteps procedure involving partial this ‘‘genomic’’ action belong to the steroid nuclear receptor protein purification steps to serve as an antigen to produce superfamily. monoclonal antibodies, a novel receptor–capture assay to The main characteristics of this process are therefore a isolate the antibodies recognizing the putative progestin delay of many hours between hormone treatment (release/ receptors, and the screening of a library expressing proteins administration?) and related biological effects, as well as the from sea trout ovaries with this selected antibody to isolate involvement of a nuclear receptor. However, steroids have the putative membrane progestin receptor cDNA. This meth- 2010/003 Article in press - uncorrected proof 42 A. Salhi et al. membrane domains, they exhibit an inverted topology when compared with G-protein-coupled receptors (GPCRs). Membrane progestin receptors function as GPCRs Although some members of the PAQR family are unrelated to GPCRs, observations reported by the Peter Thomas group indicate that mPRs display functional characteristics of this class of receptors. First of all, in contrast to adiponectin receptors and RKTG, the topology of mPR, as described by the Peter Thomas group, is that of a GPCR. In the original description (13, 14), the topology of mPR, with seven trans- membrane domains and an extracellular N-terminus part, was only extrapolated from in silico sequence analysis. Later, they showed that an antibody directed against the N-terminal part of sea trout mPRa recognized its target in non-permea- bilized cells, thereby establishing the extracellular localiza- Figure 1 Schematic representation of classical and non-classical tion of the N-terminal tail (21, 22). It should be underscored steroid actions. Steroids elicit classical, genomic effects (1) by binding to specific that the presence of seven transmembrane domains has never nuclear receptors (NRs) which then dimerize and are translocated been experimentally proven: neither for mPR nor for any into the nucleus. The steroid-bound receptor recruits different co- PAQR members. The main evidence of the Peter Thomas regulator forming a transcription complex and then binds to a hor- group suggesting that mPR are GPCRs was first obtained in mone response element (HRE) and triggers gene transcription. cells stably transfected with sea trout mPRa, where addition Steroids can also trigger rapid, non-classical effects in different of either progesterone or 20b-S induced a pertussis toxin- ways: disturbance of the lipid bilayer fluidity and modulation of sensitive decrease of cAMP, suggesting an inhibition of the membrane protein activity (2), binding to a pool of nuclear receptors adenylyl cyclases by a G0 or a Gi protein (13). Later, using present at the cell surface (3), release of nuclear receptor co-regu- native tissue, they demonstrated an interaction between 4 lators (Co-R) having their own activity ( ), and binding to mPRa or b with the inhibitory G protein in human myo- membrane-bound receptors (5). i metrial cells (23). More recently, Tubbs and Thomas (24, 25) showed that progestin-induced sperm hypermotility was od successfully led to the identification of a new class of related to mPRa stimulation followed by activation of a protein, called mPRs (13, 14). Research for orthologs stimulatory olfactory G protein (Golf) which induces an revealed that mPRs are well conserved in different species increase in intracellular cAMP. Thus, depending on tissues including mammals and particularly humans. In vertebrates, or cells, mPR could be associated with either an inhibitory there are at least three classes of receptors (a, b, and g) or a stimulatory G protein inducing opposite effects on which are differentially distributed and share 50–60% of cAMP cellular content. This observation is intriguing as homology at the protein level. The a receptor is mainly many tissues or cells expressed both Gi and Golf proteins. found in sex organs and to a lesser extent in the bladder, the The question is therefore how mPRs ‘‘choose’’ which G pro- adrenal glands, and the kidney. The b form is only neuronal tein they should associate with. The MAP kinase pathway is and the g form is found in epithelial tissues. It is noteworthy also triggered by activation of mPR proteins (13) but the link that the kidney is, so far, the only organ to express two with GPCR activity has not been established. forms, the a and the g receptors. A more detailed study regarding this non-reproductive organ has shown specific Subcellular localization of mPR localization of these isoforms along the nephron without any incidence of gender on their level of expression (15). Supporting this GPCR function, the Peter Thomas group According to their sequences, the three isoforms, mPRa, b, consistently observed the expression of mPR (irrespective of and g belong to a family of protein comprising adiponectin the isoform or the species) at the plasma membrane by using receptors 1 and 2, osmotin receptor, and RKTG (Raf Kinase different techniques (13, 21, 22). However, these authors also Trapping in Golgi also referred to as PAQR3) (16–18). This reported the co-localization
Recommended publications
  • Peripheral Nervous System……………………………………………….9
    PhD School in Integrative Biomedical Research Department of Pharmacological and Biomolecular Sciences Curriculum: Neuroscience Molecular basis for the development of innovative therapies for peripheral neuropathies treatment: role and cross-regulation of the GABAergic system and neuroactive steroids SDD BIO/09 - Physiology Luca Franco Castelnovo Badge number R10402 PhD Tutor: Prof. Valerio Magnaghi PhD School Coordinator: Prof. Chiarella Sforza Academic year 2015/2016 INDEX Abstract…………………………………………………………………...page 1 Abbreviations list…………………………………………………………….....5 Introduction………………………………………………………………….....8 Peripheral nervous system……………………………………………….9 General concepts……………...……….……………………………........……..9 Sensory system and nociceptive fibers.………………..………….…………..12 Schwann cells and myelination……….……..………………...………………15 Peripheral neuropathies…….…………………………………………...26 General concepts……………………………………………………...……….26 Neuropathic pain……………………………………...……………………….27 Nerve regeneration…………………………………………………………….28 The GABAergic system………….……………………………………...32 GABA……………….…………………………………………………..……..32 GABA-A receptors…………………………………………………………….33 GABA-B receptors…………………………………………………………….42 GABAergic system in the peripheral nervous system…………………………47 Protein kinase C – type ε……………………….………………………..51 General concepts…………………………………………………….…………51 Cross-talk with allopregnanolone and GABA-A………………………………54 Neuroactive steroids…………......………………………………………57 General concepts…………………………………….…………………………57 Mechanism of action…………………………….……………………………..59 Progesterone derivatives………………………………….……………………60
    [Show full text]
  • Nicotinic Signalling and Neurosteroid Modulation in Principal Neurons of the Hippocampal Formation and Prefrontal Cortex
    Nicotinic Signalling and Neurosteroid Modulation in Principal Neurons of the Hippocampal Formation and Prefrontal Cortex by Beryl Yik Ting Chung A Thesis presented to The University of Guelph In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Sciences and Neuroscience Guelph, Ontario, Canada © Beryl Yik Ting Chung, April, 2018 ABSTRACT NICOTINIC SIGNALLING AND NEUROSTEROID MODULATION IN PRINCIPAL NEURONS OF THE HIPPOCAMPAL FORMATION AND PREFRONTAL CORTEX Beryl Yik Ting Chung Advisor: University of Guelph, 2018 Dr. Craig D.C. Bailey Nicotinic signalling plays an important role in coordinating the response of neuronal networks in many brain regions. During pre- and postnatal circuit formation, neurotransmission mediated by nicotinic acetylcholine receptors (nAChRs) influences neuronal survival and regulates neuronal excitability, synaptic transmission, and synaptic plasticity. Nicotinic signalling is also necessary for the proper function of the hippocampal formation (HF) and prefrontal cortex (PFC), which are anatomically and functionally connected and facilitate higher-order cognitive functions. The decline or dysfunction in nicotinic signalling and nAChR function has been observed in various neurological disorders, and the disruption or alteration of nicotinic signalling in the HF and/or PFC can impair learning and memory. While the location and functional role of the α4β2* nAChR isoform has been well characterized in the medial portion of the PFC, this is not well-established in the HF. What is the role of α4β2* nAChRs in excitatory principal neurons of the HF during early development? Growing evidence suggests that the progesterone metabolite allopregnanolone (ALLO) plays a role in mediating the proper function of the HF and the PFC, and that it may also inhibit nAChR function.
    [Show full text]
  • PAQR6 Antibody (C-Term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP13667B
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 PAQR6 Antibody (C-term) Affinity Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP13667B Specification PAQR6 Antibody (C-term) - Product Information Application WB,E Primary Accession Q6TCH4 Other Accession NP_940798.1, NP_079173.2 Reactivity Human Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Calculated MW 37989 Antigen Region 283-312 PAQR6 Antibody (C-term) - Additional Information PAQR6 Antibody (C-term) (Cat. #AP13667b) Gene ID 79957 western blot analysis in Jurkat cell line lysates (35ug/lane).This demonstrates the PAQR6 Other Names antibody detected the PAQR6 protein (arrow). Progestin and adipoQ receptor family member 6, Progestin and adipoQ receptor family member VI, PAQR6 PAQR6 Antibody (C-term) - Background Target/Specificity The function of this protein remains unknown. This PAQR6 antibody is generated from rabbits immunized with a KLH conjugated PAQR6 Antibody (C-term) - References synthetic peptide between 283-312 amino acids from the C-terminal region of human PAQR6. Kamatani, Y., et al. Nat. Genet. 42(3):210-215(2010) Dilution Smith, J.L., et al. Steroids WB~~1:1000 73(11):1160-1173(2008) Tang, Y.T., et al. J. Mol. Evol. Format 61(3):372-380(2005) Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. Storage Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. Precautions PAQR6 Antibody (C-term) is for research Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 use only and not for use in diagnostic or therapeutic procedures.
    [Show full text]
  • PAQR6 (NM 001272108) Human Tagged ORF Clone – RG236776
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RG236776 PAQR6 (NM_001272108) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: PAQR6 (NM_001272108) Human Tagged ORF Clone Tag: TurboGFP Symbol: PAQR6 Synonyms: PRdelta Vector: pCMV6-AC-GFP (PS100010) E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RG236776 representing NM_001272108. Sequence: Blue=ORF Red=Cloning site Green=Tag(s) GCTCGTTTAGTGAACCGTCAGAATTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTG GATCCGGTACCGAGGAGATCTGCCGCCGCGATCGCC ATGCTCAGTCTCAAGCTGCCCCAACTTCTTCAAGTCCACCAGGTCCCCCGGGTGTTCTGGGAAGATGGC ATCATGTCTGGCTACCGCCGCCCCACCAGCTCGGCTTTGGACTGTGTCCTCAGCTCCTTCCAGATGACC AACGAGACGGTCAACATCTGGACTCACTTCCTGCCCACCTGTTTCCTGGAGCTGGAAAGCCCTGGGCTC AGTAAGGTCCTCCGCACAGGAGCCTTCGCCTATCCATTCCTGTTCGACAACCTCCCACTCTTTTATCGG CTCGGGCTGTGCTGGGGCAGGGGCCACGGCTGTGGGCAGGAGGCCCTGAGCACCAGCCATGGCTACCAT CTCTTCTGCGCGCTGCTCACTGGCTTCCTCTTCGCCTCCCACCTGCCTGAAAGGCTGGCACCAGGACGC TTTGATTACATCGGCCACAGCCACCAGTTATTCCACATCTGTGCAGTGCTGGGCACCCACTTCCAGCTG GAGGCAGTGCTGGCTGATATGGGATCACGCAGAGCCTGGCTGGCCACACAGGAACCTGCCCTGGGCCTG GCAGGCACAGTGGCCACACTGGTCTTGGCTGCAGCTGGGAACCTACTCATTATTGCTGCTTTCACAGCC ACCCTGCTTCGGGCCCCCAGTACATGCCCTCTGCTGCAGGGTGGCCCACTGGAGGGGGGTACCCAGGCC AAACAACAG ACGCGTACGCGGCCGCTCGAG - GFP Tag - GTTTAAAC This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View
    [Show full text]
  • PRODUCT SPECIFICATION Anti-PAQR9 Product
    Anti-PAQR9 Product Datasheet Polyclonal Antibody PRODUCT SPECIFICATION Product Name Anti-PAQR9 Product Number HPA052798 Gene Description progestin and adipoQ receptor family member IX Clonality Polyclonal Isotype IgG Host Rabbit Antigen Sequence Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence: IMLESWLFDLRGENPTLFVHF Purification Method Affinity purified using the PrEST antigen as affinity ligand Verified Species Human Reactivity Recommended IHC (Immunohistochemistry) Applications - Antibody dilution: 1:20 - 1:50 - Retrieval method: HIER pH6 Characterization Data Available at atlasantibodies.com/products/HPA052798 Buffer 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. Concentration Lot dependent Storage Store at +4°C for short term storage. Long time storage is recommended at -20°C. Notes Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. For protocols, additional product information, such as images and references, see atlasantibodies.com. Product of Sweden. For research use only. Not intended for pharmaceutical development, diagnostic, therapeutic or any in vivo use. No products from Atlas Antibodies may be resold, modified for resale or used to manufacture commercial products without prior written approval from Atlas Antibodies AB. Warranty: The products supplied by Atlas Antibodies are warranted to meet stated product specifications and to conform to label descriptions when used and stored properly. Unless otherwise stated, this warranty is limited to one year from date of sales for products used, handled and stored according to Atlas Antibodies AB's instructions. Atlas Antibodies AB's sole liability is limited to replacement of the product or refund of the purchase price.
    [Show full text]
  • Neuroprotection in Perimenopause New Insights for Hormone Therapy
    ISSN: 2573-9565 Review Article Journal of Clinical Review & Case Reports Neuroprotection in Perimenopause New Insights for Hormone Therapy Manuela Cristina Russu MD, Ph.D *Corresponding author Manuela Cristina Russu: “Dr I Cantacuzino” Clinic of Obstetrics and Gynecology; “Carol Davila” University of Medicine and Pharmacy, Bucharest, 5-7 Ion Movilă Professor of Obstetrics and Gynecology Street, District 2, zip code 020745. Romania Submitted: 18 Mar 2020; Accepted: 25 Mar 2020; Published: 03 Apr 2020 Abbreviations a demented status to progress from early stages of endocrine aging FMP: Final Menstrual Period process [1]. HPOA: Hypothalamic-Pituitary-Ovarian Axis MT: Menopausal Transition Update on the importance of Hormone Therapy in perimenopause VMS: Vasomotor Symptoms The menopausal transition (MT) or perimenopause– 4 to 6 years MHT: Menopausal Hormone Therapy duration [2]. with reproductive and dynamic critical changes in ERT: Estrogen Replacement Therapy hypothalamic-pituitary-ovarian axis (HPOA), and entire women’s PCC: Posterior Cingulate Cortex body, biology and psychology, starts with menstrual irregularities MCI: Mild Cognitive Impairment from the stage -3b/-3a in the late reproductive ages, with ethnic AD: Alzheimer ’s disease differences in symptoms, hormones and their receptors and actions PD: Parkinson’s Disease [3, 4]. Aβ: Beta Amyloid CVD: Cerebrovascular Disease CAA: Cerebral Amyloid Angiopathy HS: Hippocampal Sclerosis 17ß-E2: 17ß-Estradiol CEE: Conjugated Equine Estrogens ERs: Estrogen Receptors Pg: Progesterone PRs:
    [Show full text]
  • WO 2013/184908 A2 12 December 2013 (12.12.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2013/184908 A2 12 December 2013 (12.12.2013) P O P C T (51) International Patent Classification: Jr.; One Procter & Gamble Plaza, Cincinnati, Ohio 45202 G06F 19/00 (201 1.01) (US). HOWARD, Brian, Wilson; One Procter & Gamble Plaza, Cincinnati, Ohio 45202 (US). (21) International Application Number: PCT/US20 13/044497 (74) Agents: GUFFEY, Timothy, B. et al; c/o The Procter & Gamble Company, Global Patent Services, 299 East 6th (22) Date: International Filing Street, Sycamore Building, 4th Floor, Cincinnati, Ohio 6 June 2013 (06.06.2013) 45202 (US). (25) Filing Language: English (81) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (30) Priority Data: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, 61/656,218 6 June 2012 (06.06.2012) US DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (71) Applicant: THE PROCTER & GAMBLE COMPANY HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, [US/US]; One Procter & Gamble Plaza, Cincinnati, Ohio KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 45202 (US). MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, (72) Inventors: XU, Jun; One Procter & Gamble Plaza, Cincin SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, nati, Ohio 45202 (US).
    [Show full text]
  • PAQR6 (NM 198406) Human Tagged ORF Clone – RC208104
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC208104 PAQR6 (NM_198406) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: PAQR6 (NM_198406) Human Tagged ORF Clone Tag: Myc-DDK Symbol: PAQR6 Synonyms: PRdelta Vector: pCMV6-Entry (PS100001) E. coli Selection: Kanamycin (25 ug/mL) Cell Selection: Neomycin ORF Nucleotide >RC208104 ORF sequence Sequence: Red=Cloning site Blue=ORF Green=Tags(s) TTTTGTAATACGACTCACTATAGGGCGGCCGGGAATTCGTCGACTGGATCCGGTACCGAGGAGATCTGCC GCCGCGATCGCC ATGCTCAGTCTCAAGCTGCCCCAACTTCTTCAAGTCCACCAGGTCCCCCGGGTGTTCTGGGAAGATGGCA TCATGTCTGGCTACCGCCGCCCCACCAGCTCGGCTTTGGACTGTGTCCTCAGCTCCTTCCAGATGACCAA CGAGACGGTCAACATCTGGACTCACTTCCTGCCCACCTGGTACTTCCTGTGGCGGCTCCTGGCGCTGGCG GGCGGCCCCGGCTTCCGTGCGGAGCCGTACCACTGGCCGCTGCTGGTCTTCCTGCTGCCCGCCTGCCTCT ACCCCTTCGCGTCGTGCTGCGCGCACACCTTCAGCTCCATGTCGCCCCGCATGCGCCACATCTGCTACTT CCTCGACTACGGCGCGCTCAGCCTCTACAGTCTGGGCTGCGCCTTCCCCTATGCCGCCTACTCCATGCCG GCCTCCTGGCTGCACGGCCACCTGCACCAGTTCTTTGTGCCTGCCGCCGCACTCAACTCCTTCCTGTGCA CCGGCCTCTCCTGCTACTCCCGTTTCCTGGAGCTGGAAAGCCCTGGGCTCAGTAAGGTCCTCCGCACAGG AGCCTTCGCCTATCCATTCCTGTTCGACAACCTCCCACTCTTTTATCGGCTCGGGCTGTGCTGGGGCAGG GGCCACGGCTGTGGGCAGGAGGCCCTGAGCACCAGCCATGGCTACCATCTCTTCTGCGCGCTGCTCACTG GCTTCCTCTTCGCCTCCCACCTGCCTGAAAGGCTGGCACCAGGACGCTTTGATTACATCGGCCACAGCCA CCAGTTATTCCACATCTGTGCAGTGCTGGGCACCCACTTCCAGCTGGAGGCAGTGCTGGCTGATATGGGA TCACGCAGAGCCTGGCTGGCCACACAGGAACCTGCCCTGGGCCTGGCAGGCACAGTGGCCACACTGGTCT
    [Show full text]
  • Regulation Pathway of Mesenchymal Stem Cell Immune Dendritic Cell
    Downloaded from http://www.jimmunol.org/ by guest on September 26, 2021 is online at: average * The Journal of Immunology , 13 of which you can access for free at: 2010; 185:5102-5110; Prepublished online 1 from submission to initial decision 4 weeks from acceptance to publication October 2010; doi: 10.4049/jimmunol.1001332 http://www.jimmunol.org/content/185/9/5102 Inhibition of Immune Synapse by Altered Dendritic Cell Actin Distribution: A New Pathway of Mesenchymal Stem Cell Immune Regulation Alessandra Aldinucci, Lisa Rizzetto, Laura Pieri, Daniele Nosi, Paolo Romagnoli, Tiziana Biagioli, Benedetta Mazzanti, Riccardo Saccardi, Luca Beltrame, Luca Massacesi, Duccio Cavalieri and Clara Ballerini J Immunol cites 38 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2010/10/01/jimmunol.100133 2.DC1 This article http://www.jimmunol.org/content/185/9/5102.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2010 by The American Association of
    [Show full text]
  • Proteomic and Metabolomic Analyses of Biological Systems with Liquid Chromatography Tandem Mass Spectrometry and Ion Mobility Mass Spectrometry
    Graduate Theses, Dissertations, and Problem Reports 2017 Proteomic and Metabolomic Analyses of Biological Systems with Liquid Chromatography Tandem Mass Spectrometry and Ion Mobility Mass Spectrometry Megan M. Maurer Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Maurer, Megan M., "Proteomic and Metabolomic Analyses of Biological Systems with Liquid Chromatography Tandem Mass Spectrometry and Ion Mobility Mass Spectrometry" (2017). Graduate Theses, Dissertations, and Problem Reports. 6179. https://researchrepository.wvu.edu/etd/6179 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Proteomic and Metabolomic Analyses of Biological Systems with Liquid Chromatography Tandem Mass Spectrometry and Ion Mobility Mass Spectrometry Megan M. Maurer Dissertation submitted to the Eberly College of Arts and Sciences at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Analytical Chemistry Stephen J. Valentine, Ph.D., Chair Suzanne Bell, Ph.D. Glen P. Jackson, Ph.D.
    [Show full text]
  • PRODUCT SPECIFICATION Prest Antigen PAQR6 Product
    PrEST Antigen PAQR6 Product Datasheet PrEST Antigen PRODUCT SPECIFICATION Product Name PrEST Antigen PAQR6 Product Number APrEST90398 Gene Description progestin and adipoQ receptor family member VI Alternative Gene FLJ22672, PRdelta Names Corresponding Anti-PAQR6 (HPA073505) Antibodies Description Recombinant protein fragment of Human PAQR6 Amino Acid Sequence Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence: YIGEGTPGPAREEAGADAFPEHRMNWATATSYSTSVQCWAPTSSWRQCWL IWDHAEPGWPHRNLPWAWQAQWPHWSWLQL Fusion Tag N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) Expression Host E. coli Purification IMAC purification Predicted MW 27 kDa including tags Usage Suitable as control in WB and preadsorption assays using indicated corresponding antibodies. Purity >80% by SDS-PAGE and Coomassie blue staining Buffer PBS and 1M Urea, pH 7.4. Unit Size 100 µl Concentration Lot dependent Storage Upon delivery store at -20°C. Avoid repeated freeze/thaw cycles. Notes Gently mix before use. Optimal concentrations and conditions for each application should be determined by the user. Product of Sweden. For research use only. Not intended for pharmaceutical development, diagnostic, therapeutic or any in vivo use. No products from Atlas Antibodies may be resold, modified for resale or used to manufacture commercial products without prior written approval from Atlas Antibodies AB. Warranty: The products supplied by Atlas Antibodies are warranted to meet stated product specifications and to conform to label descriptions when used and stored properly. Unless otherwise stated, this warranty is limited to one year from date of sales for products used, handled and stored according to Atlas Antibodies AB's instructions. Atlas Antibodies AB's sole liability is limited to replacement of the product or refund of the purchase price.
    [Show full text]
  • The Effects of Ovarian Hormones on Memory Bias and Progesterone Receptors in Female Rats
    The Effects of Ovarian Hormones on Memory Bias and Progesterone Receptors in Female Rats by Smita Patel A Thesis Submitted to the Department of Psychology Concordia University, Quebec In Partial Fulfillment of the Requirements for the Degree of Master of Arts (Psychology) August 2020 © Smita Patel, 2020 iii CONCORDIA UNIVERSITY School of Graduate Studies This is to certify that the thesis prepared By: Smita Patel Entitled: Effects of Ovarian Hormones on Memory Bias and Progesterone Receptors in Female Rats and submitted in partial fulfillment of the requirements for the degree of Master of Arts (Psychology) complies with the regulations of the University and meets the accepted standards with respect to originality and quality. Signed by the final examining committee: _____________________________________ Chair Andreas Arvanitogiannis _____________________________________ Examiner Andrew Chapman _____________________________________ Examiner Peter John Darlington _____________________________________ Thesis Supervisor Wayne Brake Approved by ____________________________________________________ Andreas Arvanitogiannis Pascale Sicotte Date ___________________________ iii ABSTRACT The Effects of Ovarian Hormones on Memory Bias and Progesterone Receptors in Female Rats Smita Patel, MA Concordia University, 2020 Ovarian hormones can bias female rats to use one memory system over another when navigating a novel or familiar environment, resulting in a memory bias. High levels of estrogen (E) promotes places memory while low level of E promotes response memory. However, little is known about the effects of progesterone (P) on memory bias. Experiment 1 determined whether P affects memory bias. Ovariectomized (OVX) female rats were trained in a plus- shaped maze, which assesses memory system bias, and received one of three hormonal treatments: Low 17β estradiol (E2), high E2 or high E2 + P.
    [Show full text]